The importance of LAG3 as an immune checkpoint on both effector T cells and regulatory T cells has been demonstrated in multiple disease models, including type 1 diabetes (19), Parkinson’s disease (16), allogeneic bone marrow transplant (20), and cancer (21). Here, LAG3 is linked to cancer.